Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid
Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid
复制标题
DOI:
10.1016/j.neuroscience.2007.12.041
复制
发表时间:
2008-03-18
期刊:
影响因子:
3.3
通讯作者:
Ueda, H.
中科院分区:
文献类型:
--
作者:
Inoue, M.;Xie, W.;Ueda, H.
Lysophosphatidic acid receptor (LPA(1)) signaling initiates neuropathic pain and several pathological events in a partial sciatic nerve injury model. Recently, we reported that lysophosphatidic acid (LPA) induces neuropathic pain as well as demyelination and pain-related protein expression changes via LPA, receptor signaling. Lysophosphatidylcholine (LPC), also known as lysolecithin, which is hydrolyzed by autotaxin/ATX into LPA, induces similar plastic changes. Here, we attempted to clarify whether ATX and LPA(1) receptor signaling is involved in the LPC-induced neuropathic pain. In wild-type mice, a single intrathecal (i.t.) injection of LPC induced mechanical allodynia and thermal hyperalgesia 2 days after injection; this persisted for 7 days at least. On the other hand, LPC-induced mechanical allodynia and thermal hyperalgesia were completely abolished in mice lacking an LPA, receptor gene. Furthermore, the LPC-induced response was also significantly, but partially reduced in heterozygous mutant mice for the ATX gene. These findings suggest that intrathecally-injected LPC is converted to LPA by ATX, and this LPA activates the LPA, receptor to initiate neuropathic pain. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.